Pfizer Inc. is licensing its experimental Covid-19 antiviral to a global health organization in an effort to make the pill more readily available to people in low- and middle-income countries.

Under the licensing agreement, the United Nations-backed Medicines Patent Pool will work with other drugmakers to manufacture the pill for use in 95 countries, including in sub-Saharan Africa, Pfizer and the nonprofit said Tuesday.

This post first appeared on wsj.com

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Ron DeSantis to Launch 2024 Presidential Run in Twitter Talk With Elon Musk

Share Listen (1 min) This post first appeared on wsj.com

Dallas police won’t pursue sexual assault charges against Cowboys’ quarterback Dak Prescott

Dallas police said Cowboys’ quarterback Dak Prescott will not be charged after…

The pilot who suffered a medical emergency midflight is home from the hospital

The pilot who fell unconscious last week during a flight landed by a…

U.S. Accuses Google of Abusing Monopoly in Ad Technology

The Justice Department and a group of states sued Google on Tuesday,…